文献速递内脏/肾动脉与血管畸形

Protege EverFlex自膨式裸支架介入治疗自发性孤立性内脏动脉夹层的疗效

Results Obtained with the Protege EverFlex Self-expanding Bare Stent in Interventional Treatment of Spontaneous Isolated Visceral Artery Dissection.
PubMed 文献 · Ann Vasc Surg · 2021-08-17

该回顾性研究纳入2014年7月至2020年9月两家医院的28例有症状的自发性孤立性内脏动脉夹层患者,均采用Protege EverFlex自膨式裸支架行腔内治疗。所有患者支架植入成功,真腔血流恢复,残余狭窄率低于30%,技术成功率100%,无并发症,腹痛均缓解或消失。结论认为该方法是微创、安全、有效的治疗选择,成功率高且价格相对较低。

要点

  • 28例有症状的自发性孤立性内脏动脉夹层患者均成功植入Protege EverFlex自膨式裸支架。
  • 技术成功率100%,残余狭窄率低于30%,无出血、肠坏死等并发症。
  • 所有患者腹痛缓解或消失,提示腔内裸支架治疗安全有效。

核心结论

  • Protege EverFlex自膨式裸支架行腔内治疗是自发性孤立性内脏动脉夹层的微创、安全、有效方法,成功率高且价格相对较低。

研究设计与样本

  • 回顾性分析2014年7月至2020年9月两家医院28例有症状的自发性孤立性内脏动脉夹层患者,均经CTA诊断并接受Protege EverFlex自膨式裸支架腔内治疗。

主要发现

  • 28例患者均成功植入Protege EverFlex支架,术中真腔血流恢复。
  • 残余狭窄率低于30%,技术成功率100%。
  • 无出血、肠坏死、消化道穿孔、肝衰竭或脾梗死等并发症。
  • 所有患者腹痛缓解或消除。

关键数值与推荐

  • 残余狭窄率低于30%,技术成功率100%。
  • 所有患者均有急性持续性腹痛伴不同程度恶心呕吐,经多排CT血管造影(CTA)诊断。

临床怎么用

  • 对于有症状的自发性孤立性内脏动脉夹层,可考虑采用Protege EverFlex自膨式裸支架行腔内治疗。

局限性

  • 回顾性分析,样本量28例,来自两家医院,随访时间未明确报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We evaluated the early and midterm results of the endovascular approach with a certain type of bare stent to treat spontaneous isolated visceral artery dissection (SIVAD). METHODS: 28 patients with symptomatic SIVAD were selected from two hospitals from July 2014 to September 2020. All patients had symptoms of acute persistent abdominal pain accompanied by varying degrees of nausea and vomiting. The diagnosis of SIVAD was made according to the multidetector CT angiography (CTA) findings. We retrospectively analyzed the patients' medical records. According to our previous clinical experience, the Protege EverFlex self-expanding bare stent was used in these patients, and we subsequently followed up the patients to record and analyze their outcomes after surgery. The imaging results before and after the operations were compared. RESULTS: All 28 patients were successfully implanted with Protege EverFlex stents. The true lumen blood flow of the SIVAD recovered during the operation. The residual stenosis rate was less than 30%, and the technical success rate was 100%. There were no complications, such as bleeding, intestinal necrosis, digestive tract perforation, liver failure or spleen infarction. The abdominal pain was relieved or eliminated in all patients. CONCLUSION: The Protege EverFlex self-expanding bare stent and the endovascular approach could be a minimally invasive, safe and effective treatment method for SIVAD with a high success rate and a relatively low price.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gao F, Huang X, Ren D, et al. Results Obtained with the Protege EverFlex Self-expanding Bare Stent in Interventional Treatment of Spontaneous Isolated Visceral Artery Dissection. Ann Vasc Surg. 2021. PMID: 34416281. doi:10.1016/j.avsg.2021.05.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。